All News

According to the numbers, at-home test kits are going to continue to be an area of market growth.

A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.

A universal antidote for factor Xa inhibitors has entered phase 2 studies.

NSAIDs plus ACE inhibitors or ARBs can increase risk of kidney injury for patients taking diuretics.

Recent data were released on a long-term, open-label extension study evaluating clobazam for the adjunctive treatment of drop seizures.

Auto-programming infusion pumps reduces keystroke error and increases patient safety.

Pharmacy techs speak out.

Are pharmacists losing the love?

CMS recently approved 106 new ACOs in Medicare, including three of Walgreens' health networks.

Healthcare professionals can now report errors and near-misses that are associated with vaccine administration.

More patients are turning to the Internet and mobile applications (apps) with the explosive growth of mobile technology devices.

The public is generally satisfied with cancer research progress over the past 20 years. However, they believe it takes too long for new cancer drugs to reach patients and that their countries invest too little in fighting cancer, according a global survey.